Literature DB >> 33329932

Positron emission tomography objective parameters for assessment of left ventricular assist device infection using 18F-FDG PET/CT.

Saul N Friedman1,2, Maryam Mahmood3, Jennifer R Geske4, Muhammad Rizwan Sohail3,5,6, Geoffrey B Johnson1,7, John M Stulak8, Ayse Tuba Kendi1.   

Abstract

Left ventricular assist device (LVAD) is a life-saving therapy, but it poses a substantial infection risk. Current evaluation of LVAD infection with 18F-FDG PET/CT is predominately subjective. We present qualitative and semi-quantitative 18F-FDG PET/CT parameters for early detection of LVAD infection and site localization. We retrospectively reviewed all 25 LVAD patients at our institution who had undergone 18F-FDG PET/CT imaging between 2014 and 2018. LVADs were subdivided into five assessed regions: driveline exit site, subcutaneous driveline, LVAD pump, LVAD inflow, and LVAD outflow cannulae. Ultimate diagnosis of LVAD infection was determined by a multidisciplinary primary care team. Qualitative and semi-quantitative analysis of PET/CT data were performed, including calculation of the standardized uptake value maximum, mean, and peak (SUVmax, SUVmean, and SUVpeak, respectively), as well as metabolic tumor volume (MTV), and total lesion glycolysis (TLG). A total of 14 patients presented with symptoms of infection, and LVAD infection was ultimately diagnosed in 19 of the 25 cases. All cases were correctly identified on 18F-FDG PET/CT with no false positive and no false negative cases, corresponding to a sensitivity and specificity of 100%. The mean SUVmax range at noninfected sites was 2.5-3.4, and the range was 5.7-8.1 at infected sites, resulting in a significant difference (P < 0.01) at all LVAD regions. 18F-FDG PET/CT is a useful adjunctive tool for assessment of LVAD infection and infection localization, which is crucial for clinical management. A cut-off SUVmax 5 is recommended to help diagnose LVAD infection. AJNMMI
Copyright © 2020.

Entities:  

Keywords:  FDG; LVAD; MCSD; PET; cardiac; infection

Year:  2020        PMID: 33329932      PMCID: PMC7724280     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  26 in total

1.  Infections in patients using ventricular-assist devices: Comparison of the diagnostic performance of 18F-FDG PET/CT scan and leucocyte-labeled scintigraphy.

Authors:  Carole de Vaugelade; Charles Mesguich; Karine Nubret; Fabrice Camou; Carine Greib; Gael Dournes; Frédéric Debordeaux; Elif Hindie; Laurent Barandon; Ghoufrane Tlili
Journal:  J Nucl Cardiol       Date:  2018-06-12       Impact factor: 5.952

2.  Contributory Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis and Clinical Management of Infections in Patients Supported With a Continuous-Flow Left Ventricular Assist Device.

Authors:  Angelo Maria Dell'Aquila; Stefano Mastrobuoni; Sebastian Alles; Christian Wenning; Welp Henryk; Stefan Rudolf Bertram Schneider; Heinz Deschka; Jürgen R Sindermann; Mirela Scherer
Journal:  Ann Thorac Surg       Date:  2015-10-01       Impact factor: 4.330

Review 3.  An update on the role of 18F-FDG-PET/CT in major infectious and inflammatory diseases.

Authors:  Boom Ting Kung; Siavash Mehdizadeh Seraj; Mahdi Zirakchian Zadeh; Chaitanya Rojulpote; Esha Kothekar; Cyrus Ayubcha; Kwok Sing Ng; Koon Kiu Ng; Ting Kun Au-Yong; Thomas J Werner; Hongming Zhuang; Stephen J Hunt; Søren Hess; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2019-12-15

4.  (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis.

Authors:  Jelle Van Riet; Evelyn E Hill; Olivier Gheysens; Steven Dymarkowski; Marie-Christine Herregods; Paul Herijgers; Willy E Peetermans; Luc Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-04       Impact factor: 9.236

5.  Use of a continuous-flow device in patients awaiting heart transplantation.

Authors:  Leslie W Miller; Francis D Pagani; Stuart D Russell; Ranjit John; Andrew J Boyle; Keith D Aaronson; John V Conte; Yoshifumi Naka; Donna Mancini; Reynolds M Delgado; Thomas E MacGillivray; David J Farrar; O H Frazier
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

6.  FDG PET/CT for Early Detection and Localization of Left Ventricular Assist Device Infection: Impact on Patient Management and Outcome.

Authors:  Jongho Kim; Erika D Feller; Wengen Chen; Yuanyuan Liang; Vasken Dilsizian
Journal:  JACC Cardiovasc Imaging       Date:  2018-03-14

7.  Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in ¹⁸F-FDG PET Imaging.

Authors:  Asbjørn M Scholtens; Hein J Verberne; Ricardo P J Budde; Marnix G E H Lam
Journal:  J Nucl Med       Date:  2015-12-10       Impact factor: 10.057

8.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

9.  18F-FDG PET/CT-imaging of left ventricular assist device infection: a retrospective quantitative intrapatient analysis.

Authors:  Philipp Kanapinn; Wolfgang Burchert; Hermann Körperich; Jan Körfer
Journal:  J Nucl Cardiol       Date:  2018-01-16       Impact factor: 5.952

10.  National Trends in Utilization, Mortality, Complications, and Cost of Care After Left Ventricular Assist Device Implantation From 2005 to 2011.

Authors:  Neeraj Shah; Vratika Agarwal; Nileshkumar Patel; Abhishek Deshmukh; Ankit Chothani; Jalaj Garg; Apurva Badheka; Matthew Martinez; Nauman Islam; Ronald Freudenberger
Journal:  Ann Thorac Surg       Date:  2015-11-14       Impact factor: 4.330

View more
  2 in total

Review 1.  Molecular imaging in oncology: Current impact and future directions.

Authors:  Steven P Rowe; Martin G Pomper
Journal:  CA Cancer J Clin       Date:  2021-12-13       Impact factor: 286.130

Review 2.  Nuclear Imaging in Infective Endocarditis.

Authors:  Nidaa Mikail; Fabien Hyafil
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.